Search Results 891-900 of 18372 for prostate cancer
A Study Comparing Orteronel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer, Who Have Not Had Chemotherapy · Share · Facebook ...
A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft. Rochester, Minn. The purposes of this study are to collect prostate ...
Stage 4 prostate cancer begins in the prostate and grows to nearby organs or spreads to other areas of the body. Learn the symptoms, treatments and ways to cope ...
, Kidney stone, Kidney cancer, Prostate cancer, Bladder cancer, Ureteral obstruction, Benign prostatic hyperplasia, Voiding dysfunction ... tumor, Mediastinal ...
Define actionable vulnerabilities of drug-tolerant cancer stem cells in prostate cancer and other tumor types. Develop and study derived xenograft and ...
... prostate cancer or biochemically recurrent prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
This medicine will not prevent prostate cancer but may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns ...
While it's not the same as prostate cancer, an enlarged prostate can cause significant quality of life issues. Dr. Scott Cheney, a Mayo Clinic urologist ...
177Lu-PSMA-617 Vs. Androgen Receptor-directed Therapy In The Treatment Of Progressive Metastatic Castrate Resistant Prostate Cancer. Print details. Share ...
... prostate cancer. The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.